Having received FDA approval last July, Zogenix is bringing to market its SUMAVEL DosePro sumatriptan delivery system for the treatment of oncoming migraines and cluster headaches. The needle-free device delivers the drug subcutaneously, bringing both speed and efficacy when oral pills are a poor option. According to the company, migraine relief starts within 10 minutes for some patients.
It should be available at most retail pharmacy outlets this month.
SUMAVEL DosePro offers other practical benefits. Approximately 30 percent of patients report vomiting as a symptom of migraine attacks. During these episodes, oral therapies may be an impractical treatment option.
Further, while most forms of triptans can be effective when taken early in a migraine attack, patients who experience rapid onset of migraines, or those that occur upon waking may not always achieve the fast relief they would like from tablet and nasal forms. Quickly absorbed subcutaneous sumatriptan may offer an alternative for these patients, although until now, it was only available in a needle-based system.